Regulatory News
Wednesday, November 16, 2016
BRIEF-Cumberland Pharmaceuticals acquires U.S. rights to Nordic Group's methotrexate injection products
* Says it will register and commercialize methotrexate
products in United States
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment